Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with

Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with — المؤلف: Uchida, Akiko — Haematologica 20200602

المؤلف
Uchida, Akiko
النشر
Haematologica 20200602
الوصف
1417-1421 p.
الموضوعات
Antineoplastic Agents؛ Apoptosis؛ Bridged Bicyclo Compounds, Heterocyclic؛ Cell Proliferation؛ Gene Rearrangement؛ Humans؛ Lymphoma, Large B-Cell, Diffuse؛ Proto-Oncogene Proteins c-bcl-2